Author:
Xu Yi,Yang Shuofei,Xue Guanhua
Abstract
The abdominal aortic aneurysm (AAA) is characterized by segmental expansion of the abdominal aorta and a high mortality rate. The characteristics of AAA suggest that apoptosis of smooth muscle cells, the production of reactive oxygen species, and inflammation are potential pathways for the formation and development of AAA. Long non-coding RNA (lncRNA) is becoming a new and essential regulator of gene expression. Researchers and physicians are focusing on these lncRNAs to use them as clinical biomarkers and new treatment targets for AAAs. LncRNA studies are beginning to emerge, suggesting that they may play a significant but yet unidentified role in vascular physiology and disease. This review examines the role of lncRNA and their target genes in AAA to increase our understanding of the disease’s onset and progression, which is crucial for developing potential AAA therapies.
Subject
Genetics (clinical),Genetics,Molecular Medicine
Reference101 articles.
1. Cellular content and permeability of intraluminal thrombus in abdominal aortic aneurysm;Adolph;J. Vasc. Surg.,1997
2. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression;Aguilo;Cancer Res.,2011
3. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: An international, randomised, double-blind, placebo-controlled trial;Anand;Lancet (London, Engl.,2018
4. The role of long non-coding RNAs in genome formatting and expression;Angrand;Front. Genet.,2015
5. Mural thrombus and the progression of abdominal aortic aneurysms: A large population-based prospective cohort study;Behr-Rasmussen;Eur. J. Vasc. endovascular Surg. official J. Eur. Soc. Vasc. Surg.,2014
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献